In the contemporary medical landscape, the term "Disposable" is no longer sufficient. Global healthcare procurement mandates are shifting toward biocompatibility and chemical neutrality. As a leading China Non-Toxic Syringe Supplier, Hangzhou JZCare Medical Co., Ltd. recognizes that the syringe is not merely a plastic vessel, but a critical interface between life-saving medicine and the human body.
Annual Units Capacity
Modern Factory Space
Global Export Markets
Certified Quality Mgmt
The core of our "Non-Toxic" commitment lies in the elimination of potentially harmful plasticizers such as DEHP (Diethylhexyl phthalate) and BPA. By utilizing high-purity medical-grade Polypropylene (PP), JZCare ensures that medicines—whether they are viscous vaccines or sensitive insulin—remain untainted by chemical leaching, a phenomenon known as Leachable and Extractable (L&E) contamination.
Procurement directors at NGOs, government health ministries, and multinational hospital groups face a dual challenge: maintaining strict safety standards while optimizing cost-efficiency. Our role as a senior Syringe Exporter is to provide integrated macro-solutions that go beyond the product itself.
With an annual capacity exceeding 1.5 billion units, we mitigate the risk of clinical shortages during surge demand periods, such as seasonal flu cycles or global immunization campaigns.
Our syringes meet WHO PQS standards and CE/ISO certifications, facilitating seamless customs clearance and regulatory approval in over 80 countries.
Through vertically integrated manufacturing—from precision injection molding to automated EO sterilization—we deliver "Best in Class" ROI for healthcare budgets.
Operating out of Hangzhou, one of China's premier tech hubs, JZCare leverages advanced logistics networks. We offer localized support through flexible OEM/ODM agreements, allowing regional distributors to customize needle gauges (from 29G to 31G for insulin) and packaging (blister or poly-bag) to meet local clinical preferences.
Our R&D department is currently executing a 5-year technical roadmap focused on Safety Engineering and Sustainability. The future of non-toxic syringes involves three major pillars:
Hangzhou JZCare Medical Co., Ltd. operates 26,000 square meters of high-tech facility. Our cleanroom workshops are monitored 24/7 for particulate count and microbial presence. By employing more than 300 specialists, we ensure that every syringe, whether it is a 1ml Tuberculin or a 20ml Veterinary injector, undergoes a rigorous multi-stage quality check.
We provide specialized configurations for diverse industrial and clinical sectors:
Luer Lock and Auto-Disable syringes designed for large-scale public health initiatives, ensuring needle security and dosage accuracy.
Ultra-fine needles (29G-31G) integrated into non-toxic barrels to provide a painless and safe experience for chronic home-care patients.
High-durability syringes for livestock and pets, including long-distance injectors and specialized oral feeding syringes.
Advanced medical contrast injection systems compatible with CT/MRI radiography equipment for precision diagnostic workflows.
Founded in 2011, Hangzhou JZCare Medical Co., Ltd. has grown from a specialized manufacturer to a global healthcare partner. Our commitment to provide "safe, efficient, and cost-effective medical disposable solutions" is backed by a 26,000sqm facility that integrates research, precision molding, and global supply chain management. We don't just export products; we export quality assurance and patient safety.
For global procurement inquiries, customized technical specifications, or large-scale tender support, JZCare stands ready to deliver excellence.
JZCare Syringe
